Abstract
In Italy, Cyclosporin (CYS) is the drug that is electively used, together with steroids, to prevent rejection after liver transplantation (OLTX). The early (i.e. hypertension, kidney failure) and late (i.e. gingival hypertrophy, hirsutism, lymphoma) side effects caused by CYS use are well recognized entities (1). The damage to the graft, during the early postoperative period, is difficult to demonstrate and analyze. The aim of the present study is to evaluate the incidence of early and late side effects in high risk patients that did not receive any other rejection prophylaxis regime (e.g. OKT3, ATG) but steroids and azathioprine.KeywordsHigh Risk PatientHerpes ZosterAcute RejectionBiliary AtresiaFulminant HepatitisThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
